Gilead Sciences, Inc. (GILD)
167.95
-1.78
(-1.05%)
USD |
NASDAQ |
Nov 12, 16:00
168.13
+0.18
(+0.11%)
After-Hours: 07:42
Gilead Sciences Total Liabilities (Quarterly) : 38.45B for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 38.45B |
| June 30, 2026 | 37.62B |
| March 31, 2026 | 32.85B |
| December 31, 2025 | 36.40B |
| September 30, 2025 | 37.08B |
| June 30, 2025 | 36.13B |
| March 31, 2025 | 37.36B |
| December 31, 2024 | 39.75B |
| September 30, 2024 | 36.13B |
| June 30, 2024 | 35.38B |
| March 31, 2024 | 38.84B |
| December 31, 2023 | 39.38B |
| September 30, 2023 | 40.13B |
| June 30, 2023 | 41.24B |
| March 31, 2023 | 40.94B |
| December 31, 2022 | 41.96B |
| September 30, 2022 | 41.50B |
| June 30, 2022 | 42.66B |
| March 31, 2022 | 43.16B |
| December 31, 2021 | 46.89B |
| September 30, 2021 | 45.63B |
| June 30, 2021 | 48.27B |
| March 31, 2021 | 48.53B |
| December 31, 2020 | 50.19B |
| September 30, 2020 | 43.41B |
| Date | Value |
|---|---|
| June 30, 2020 | 37.79B |
| March 31, 2020 | 37.56B |
| December 31, 2019 | 38.98B |
| September 30, 2019 | 38.41B |
| June 30, 2019 | 40.46B |
| March 31, 2019 | 40.75B |
| December 31, 2018 | 42.14B |
| September 30, 2018 | 41.30B |
| June 30, 2018 | 43.62B |
| March 31, 2018 | 44.73B |
| December 31, 2017 | 49.78B |
| September 30, 2017 | 39.41B |
| June 30, 2017 | 37.17B |
| March 31, 2017 | 36.78B |
| December 31, 2016 | 37.61B |
| September 30, 2016 | 39.25B |
| June 30, 2016 | 33.86B |
| March 31, 2016 | 33.75B |
| December 31, 2015 | 32.60B |
| September 30, 2015 | 32.69B |
| June 30, 2015 | 22.53B |
| March 31, 2015 | 20.73B |
| December 31, 2014 | 18.84B |
| September 30, 2014 | 14.98B |
| June 30, 2014 | 14.78B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 10.91B |
| AbbVie, Inc. | 152.22B |
| Biogen, Inc. | 13.13B |
| Vertex Pharmaceuticals, Inc. | 11.83B |
| Amgen, Inc. | 81.70B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 51.41B |
| Shareholders Equity (Quarterly) | 13.04B |
| Debt to Equity Ratio | 2.012 |
| Current Ratio | 1.379 |
| Net Debt Paydown Yield | -0.14% |